Intas Pharmaceuticals Limited Cabazitaxel Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Cabazitaxel Export Records India — #1 Exporter, 108 Shipments, $3.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Cabazitaxel

India Pharmaceutical Trade Intelligence

$9.2M59 Suppliers49 CountriesHS 30049049

ExportsIndia → RUSSIA25.7%India → ITALY14.8%

ImportsCANADA → India$304.7K UNITED STATES → India$105.3K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: ACCORD HEALTHCARE

Intas Pharmaceuticals Limited — Cabazitaxel Exporter #1 | $3.7M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Cabazitaxel Exporter Profile

Indian Pharmaceutical Exporter · #1 for Cabazitaxel · $3.7M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #1 Indian exporter of Cabazitaxel with $3.7M in export value and 108 verified shipments. Intas Pharmaceuticals Limited holds a 38.4% market share in Cabazitaxel exports across 9 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Cabazitaxel Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Cabazitaxel export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Cabazitaxel?

Country	Value	Shipments	Share
NETHERLANDS	$686.7K	21	43.8%
POLAND	$227.9K	7	14.5%
ITALY	$179.2K	7	11.4%
UNITED KINGDOM	$133.1K	5

Who Are the Top Buyers of Cabazitaxel from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
ALLOGA FRANCE	NETHERLANDS	$227.6K	8
BROCACEF NL HUB	NETHERLANDS	$172.7K	4
BROCACEF NL:HUB	NETHERLANDS	$150.0K	3
ACCORD HEALTHCARE ITALIA SRL.	ITALY	$100.0K	2
ACCORD HEALTHCARE, SLU	SPAIN	$100.0K	2
ACCORD HEALTHCARE POLSKA SP. Z.O.O.	POLAND	$100.0K	2
PHARMADOX HEALTHCARE LTD	MALTA	$87.4K	30
ACCORD HEALTHCARE POLSKA SP. Z O.O.	POLAND	$70.7K	2
ACCORD HEALTHCARE PTY LTD	AUSTRALIA	$65.8K	2
BROCACEF NL : HUB	NETHERLANDS	$60.5K	3

Intas Pharmaceuticals Limited supplies Cabazitaxel to 28 buyers globally. The largest buyer is ALLOGA FRANCE (NETHERLANDS), followed by BROCACEF NL HUB (NETHERLANDS) and BROCACEF NL:HUB (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Cabazitaxel Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML	$506.2K	11
PHARMA DRUG&MED:CABAZITAXEL 20MG/ML 3ML(	$350.0K	7
PHR DRUGS&MEDI CABAZITAXEL 20MG/ML 3ML(A	$150.0K	3
PHARMA DRUGS & MEDI: CABAZITAXEL 20MG/ML	$76.5K	14
PHARMA DRUG&MED: CABAZITAXEL 20MG/ML 3ML	$50.0K	1
PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML 3MLACCORD-FISE AS PER DOCUMENT	$50.0K	1
PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML 3MLACCORD-PLROCZ AS PER DOCUMENT	$50.0K	1
PHAR.DRUGS AND MED:CABAZITAXEL ACCORD 20MG/ML,3ML 1V (ACC-AUS EACH ML CONTAINS:CABAZITAXEL 20 MG DEHYDRATED ALCOHOL PH.	$50.0K	1
PHARMA DRUG&MED: CABAZITAXEL 20MG/ML 3ML(ACCORD-UK EACH ML CONTAINS CABAZITAXEL.20.0 MG DEHYDRATED ALCOHOL PH.EUR##. 395	$30.3K	1
PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML 3ML(ACCORD-FRANCE AS PER INVOICE	$28.5K	2

Intas Pharmaceuticals Limited exports 61 distinct Cabazitaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML with 11 shipments worth $506.2K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Cabazitaxel Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED ★	$3.5M	108	9	$32.8K
2	MSN LABORATORIES PRIVATE LIMITED	$1.6M	37	8	$42.4K
3	DR REDDY S LABORATORIES LIMITED	$150.0K	3	3	$50.0K

Intas Pharmaceuticals Limited ranks #1 among 59 Indian Cabazitaxel exporters. Average shipment value of $32.8K compared to the market average of $98.5K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and DR REDDY S LABORATORIES LIMITED.

Which Indian Ports Ship Cabazitaxel Exports?

Port	Shipments	% Share
SAHAR AIR	48	15.6%
SAHAR AIR CARGO ACC (INBOM4)	45	14.7%
AHEMDABAD AIR	37	12.1%
AHEMDABAD AIR ACC (INAMD4)	32	10.4%
HYDERABAD AIR	25	8.1%
MUNDRA SEA (INMUN1)	19	6.2%
Hyderabad Air	12	3.9%
DELHI AIR CARGO ACC (INDEL4)	9	2.9%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Cabazitaxel Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cabazitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 111 individual customs records matching Intas Pharmaceuticals Limited exporting Cabazitaxel, covering 61 formulations to 9 countries via 28 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 49+ countries, 107+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cabazitaxel

Cabazitaxel

Intas Pharmaceuticals Limited — Cabazitaxel Exporter Profile

Intas Pharmaceuticals Limited — Cabazitaxel Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Cabazitaxel?

Who Are the Top Buyers of Cabazitaxel from Intas Pharmaceuticals Limited?

What Is India's Total Cabazitaxel Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Cabazitaxel Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Cabazitaxel Exporters?

What Cabazitaxel Formulations Does Intas Pharmaceuticals Limited Export?

How Does Intas Pharmaceuticals Limited Compare to Nearest Cabazitaxel Exporters?

Which Indian Ports Ship Cabazitaxel Exports?

What Other Advanced Oncology Products Does Intas Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Cabazitaxel Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cabazitaxel Export Data from Intas Pharmaceuticals Limited

Cabazitaxel Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source